Pediatric osteosarcoma - treatment of the primary tumor with intravenous cis-diamminedichloroplatinum-ii (cdp) - comparison of the results with the reported efficacy of intraarterial cdp
Intravenous cis-Diamminedichloroplatinum-II (CDP) was administered to 10 patients with osteosarcoma to treat the primary tumor in 8 and bone metastases in 2. Three patients also had pulmonary metastases. The intent was to deliver 7 courses (150 mg/M2 q 2 weeks) over 3 months (total cumulative dose 1050/mg/M2). However, this was only accomplished in 2 patients; in the remaining 8 the full course was not administered because of temporary renal insufficiency (3), tumor escape (1) and apparent response after 4-6 courses suggesting that no further benefit would accrue (4). Overall, clinical and/or radiologic responses were observed in 9 patients. In 6 of 9 tumors subjected to surgical resection (66%), necrosis in excess of 65% was observed. Optimum results were achieved with a cumulative dose of 600 mg/M2 administered over 6 weeks. These results suggest that intravenous CDP may be as efficacious as intra-arterial CDP which has produced similar responses.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1993 |
---|---|
Erschienen: |
1993 |
Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
---|---|
Enthalten in: |
International journal of oncology - 3(1993), 2 vom: 21. Aug., Seite 273-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jaffe, N [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 02.10.2012 Date Revised 06.06.2019 published: Print Citation Status PubMed-not-MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM208241337 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM208241337 | ||
003 | DE-627 | ||
005 | 20231224003632.0 | ||
007 | tu | ||
008 | 231224s1993 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0694.xml |
035 | |a (DE-627)NLM208241337 | ||
035 | |a (NLM)21573359 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jaffe, N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pediatric osteosarcoma - treatment of the primary tumor with intravenous cis-diamminedichloroplatinum-ii (cdp) - comparison of the results with the reported efficacy of intraarterial cdp |
264 | 1 | |c 1993 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 02.10.2012 | ||
500 | |a Date Revised 06.06.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Intravenous cis-Diamminedichloroplatinum-II (CDP) was administered to 10 patients with osteosarcoma to treat the primary tumor in 8 and bone metastases in 2. Three patients also had pulmonary metastases. The intent was to deliver 7 courses (150 mg/M2 q 2 weeks) over 3 months (total cumulative dose 1050/mg/M2). However, this was only accomplished in 2 patients; in the remaining 8 the full course was not administered because of temporary renal insufficiency (3), tumor escape (1) and apparent response after 4-6 courses suggesting that no further benefit would accrue (4). Overall, clinical and/or radiologic responses were observed in 9 patients. In 6 of 9 tumors subjected to surgical resection (66%), necrosis in excess of 65% was observed. Optimum results were achieved with a cumulative dose of 600 mg/M2 administered over 6 weeks. These results suggest that intravenous CDP may be as efficacious as intra-arterial CDP which has produced similar responses | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Jaffe, D |e verfasserin |4 aut | |
700 | 1 | |a Raymond, A |e verfasserin |4 aut | |
700 | 1 | |a Pearson, P |e verfasserin |4 aut | |
700 | 1 | |a Robertson, R |e verfasserin |4 aut | |
700 | 1 | |a Kim, E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of oncology |d 1992 |g 3(1993), 2 vom: 21. Aug., Seite 273-8 |w (DE-627)NLM092583830 |x 1791-2423 |7 nnns |
773 | 1 | 8 | |g volume:3 |g year:1993 |g number:2 |g day:21 |g month:08 |g pages:273-8 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 3 |j 1993 |e 2 |b 21 |c 08 |h 273-8 |